|
AU2003252765B2
(en)
*
|
1999-02-05 |
2006-06-29 |
Samsung Electronics Co., Ltd. |
Image texture retrieving method and apparatus thereof
|
|
KR100308456B1
(ko)
*
|
1999-07-09 |
2001-11-02 |
오길록 |
주파수 공간상에서의 질감표현방법 및 질감기반 검색방법
|
|
KR100355404B1
(ko)
*
|
1999-12-03 |
2002-10-11 |
삼성전자 주식회사 |
주파수 공간상에서의 가보 필터를 이용한 질감표현방법 및질감기반 영상 검색방법
|
|
US6977659B2
(en)
*
|
2001-10-11 |
2005-12-20 |
At & T Corp. |
Texture replacement in video sequences and images
|
|
US7606435B1
(en)
|
2002-02-21 |
2009-10-20 |
At&T Intellectual Property Ii, L.P. |
System and method for encoding and decoding using texture replacement
|
|
KR100908384B1
(ko)
*
|
2002-06-25 |
2009-07-20 |
주식회사 케이티 |
블록상관계수를 이용한 영역기반 질감 추출 장치 및 그 방법
|
|
JP2005122361A
(ja)
*
|
2003-10-15 |
2005-05-12 |
Sony Computer Entertainment Inc |
画像処理装置及び方法、コンピュータプログラム、記録媒体
|
|
US7415145B2
(en)
*
|
2003-12-30 |
2008-08-19 |
General Electric Company |
Methods and apparatus for artifact reduction
|
|
JP4747881B2
(ja)
*
|
2006-02-27 |
2011-08-17 |
セイコーエプソン株式会社 |
演算処理装置によるデータ変換方法、テクスチャの作成方法、プログラム、記録媒体、及びプロジェクタ。
|
|
US20090258001A1
(en)
*
|
2006-06-06 |
2009-10-15 |
Paul Ponath |
Administration of anti-CD3 antibodies in the treatment of autoimmune diseases
|
|
EP1870836A1
(de)
*
|
2006-06-22 |
2007-12-26 |
THOMSON Licensing |
Verfahren und Vorrichtung zur Bestimmung eines Deskriptors für ein Signal, das ein Multimedia-Element darstellt, Vorrichtung zur Gewinnung von Elementen in einer Datenbank, Vorrichtung zur Klassifizierung von Multimedia-Elementen in einer Datenbank
|
|
JP5358083B2
(ja)
|
2007-11-01 |
2013-12-04 |
株式会社日立製作所 |
人物画像検索装置及び画像検索装置
|
|
US7924290B2
(en)
*
|
2007-05-30 |
2011-04-12 |
Nvidia Corporation |
Method and system for processing texture samples with programmable offset positions
|
|
KR101394154B1
(ko)
|
2007-10-16 |
2014-05-14 |
삼성전자주식회사 |
미디어 컨텐츠 및 메타데이터를 부호화하는 방법과 그 장치
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
US8483431B2
(en)
|
2008-05-27 |
2013-07-09 |
Samsung Electronics Co., Ltd. |
System and method for estimating the centers of moving objects in a video sequence
|
|
US20140321756A9
(en)
*
|
2008-05-27 |
2014-10-30 |
Samsung Electronics Co., Ltd. |
System and method for circling detection based on object trajectory
|
|
US8107726B2
(en)
*
|
2008-06-18 |
2012-01-31 |
Samsung Electronics Co., Ltd. |
System and method for class-specific object segmentation of image data
|
|
US20100027845A1
(en)
*
|
2008-07-31 |
2010-02-04 |
Samsung Electronics Co., Ltd. |
System and method for motion detection based on object trajectory
|
|
US8433101B2
(en)
*
|
2008-07-31 |
2013-04-30 |
Samsung Electronics Co., Ltd. |
System and method for waving detection based on object trajectory
|
|
US8073818B2
(en)
*
|
2008-10-03 |
2011-12-06 |
Microsoft Corporation |
Co-location visual pattern mining for near-duplicate image retrieval
|
|
KR101194605B1
(ko)
*
|
2008-12-22 |
2012-10-25 |
한국전자통신연구원 |
시간 연속적 텍스쳐 합성 장치 및 방법
|
|
KR101028628B1
(ko)
|
2008-12-29 |
2011-04-11 |
포항공과대학교 산학협력단 |
영상 텍스쳐 필터링 방법, 이를 수행하는 프로그램을 기록한 기록매체 및 이를 수행하는 장치
|
|
US8321422B1
(en)
|
2009-04-23 |
2012-11-27 |
Google Inc. |
Fast covariance matrix generation
|
|
US8611695B1
(en)
|
2009-04-27 |
2013-12-17 |
Google Inc. |
Large scale patch search
|
|
US8396325B1
(en)
|
2009-04-27 |
2013-03-12 |
Google Inc. |
Image enhancement through discrete patch optimization
|
|
US8391634B1
(en)
*
|
2009-04-28 |
2013-03-05 |
Google Inc. |
Illumination estimation for images
|
|
US8385662B1
(en)
|
2009-04-30 |
2013-02-26 |
Google Inc. |
Principal component analysis based seed generation for clustering analysis
|
|
US8798393B2
(en)
|
2010-12-01 |
2014-08-05 |
Google Inc. |
Removing illumination variation from images
|
|
EP3786185A1
(de)
|
2010-12-06 |
2021-03-03 |
Seagen Inc. |
Humanisierte antikörper gegen liv-1 und deren verwendung zur behandlung von krebs
|
|
US8738280B2
(en)
*
|
2011-06-09 |
2014-05-27 |
Autotalks Ltd. |
Methods for activity reduction in pedestrian-to-vehicle communication networks
|
|
HRP20230065T1
(hr)
|
2011-10-28 |
2023-03-03 |
Prothena Biosciences Limited |
Humanizirana protutijela koja prepoznaju alfa-sinuklein
|
|
SG11201404321YA
(en)
|
2012-01-27 |
2014-08-28 |
Neotope Biosciences Ltd |
Humanized antibodies that recognize alpha-synuclein
|
|
US20130309223A1
(en)
|
2012-05-18 |
2013-11-21 |
Seattle Genetics, Inc. |
CD33 Antibodies And Use Of Same To Treat Cancer
|
|
UA118441C2
(uk)
|
2012-10-08 |
2019-01-25 |
Протена Біосаєнсиз Лімітед |
Антитіло, що розпізнає альфа-синуклеїн
|
|
MX375354B
(es)
|
2013-03-13 |
2025-03-06 |
Prothena Biosciences Ltd |
Anticuerpos que se unen a tau y usos de los mismos.
|
|
US10513555B2
(en)
|
2013-07-04 |
2019-12-24 |
Prothena Biosciences Limited |
Antibody formulations and methods
|
|
WO2015004632A1
(en)
|
2013-07-12 |
2015-01-15 |
Neotope Biosciences Limited |
Antibodies that recognize iapp
|
|
US9951131B2
(en)
|
2013-07-12 |
2018-04-24 |
Prothena Biosciences Limited |
Antibodies that recognize IAPP
|
|
KR101713690B1
(ko)
*
|
2013-10-25 |
2017-03-08 |
한국전자통신연구원 |
특징 선택 방법을 이용한 비주얼 기술자 추출 방법 및 시스템
|
|
JP2017501848A
(ja)
|
2013-11-19 |
2017-01-19 |
プロセナ バイオサイエンシーズ リミテッド |
便秘症状からのレビー小体病の免疫療法のモニター
|
|
TW201623331A
(zh)
|
2014-03-12 |
2016-07-01 |
普羅帝納生物科學公司 |
抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
|
|
JP2017514458A
(ja)
|
2014-03-12 |
2017-06-08 |
プロセナ バイオサイエンシーズ リミテッド |
Lg4−5に対して特異的な抗−ラミニン4抗体
|
|
CA2938931A1
(en)
|
2014-03-12 |
2015-09-17 |
Prothena Biosciences Limited |
Anti-laminin4 antibodies specific for lg1-3
|
|
KR20160127825A
(ko)
|
2014-03-12 |
2016-11-04 |
프로테나 바이오사이언시즈 리미티드 |
항-mcam 항체 및 관련된 사용 방법
|
|
US20170002077A1
(en)
|
2014-03-13 |
2017-01-05 |
Prothena Biosciences Limited |
Combination treatment for multiple sclerosis
|
|
US10562973B2
(en)
|
2014-04-08 |
2020-02-18 |
Prothena Bioscience Limited |
Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
|
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
|
KR102260805B1
(ko)
*
|
2014-08-06 |
2021-06-07 |
삼성전자주식회사 |
이미지 검색 장치 및 그 방법
|
|
US20160075772A1
(en)
|
2014-09-12 |
2016-03-17 |
Regeneron Pharmaceuticals, Inc. |
Treatment of Fibrodysplasia Ossificans Progressiva
|
|
KR102258100B1
(ko)
*
|
2014-11-18 |
2021-05-28 |
삼성전자주식회사 |
텍스쳐 처리 방법 및 장치
|
|
TWI718122B
(zh)
|
2015-01-28 |
2021-02-11 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
|
TWI711631B
(zh)
|
2015-01-28 |
2020-12-01 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
|
TWI781507B
(zh)
|
2015-01-28 |
2022-10-21 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
|
EP3288976B1
(de)
|
2015-04-29 |
2020-04-08 |
Regeneron Pharmaceuticals, Inc. |
Behandlung von fibrodysplasia ossificans progressiva
|
|
US10162878B2
(en)
|
2015-05-21 |
2018-12-25 |
Tibco Software Inc. |
System and method for agglomerative clustering
|
|
CN107637064A
(zh)
|
2015-06-08 |
2018-01-26 |
深圳市大疆创新科技有限公司 |
用于图像处理的方法和设备
|
|
KR101627974B1
(ko)
*
|
2015-06-19 |
2016-06-14 |
인하대학교 산학협력단 |
영상 블러에 강인한 영상 특징 기술자 생성 방법 및 장치
|
|
CN116063502A
(zh)
|
2015-06-30 |
2023-05-05 |
西雅图基因公司 |
抗ntb-a抗体和相关组合物以及方法
|
|
CN105183752B
(zh)
*
|
2015-07-13 |
2018-08-10 |
中国电子科技集团公司第十研究所 |
关联查询红外视频图像特定内容的方法
|
|
EP3350226A2
(de)
|
2015-09-16 |
2018-07-25 |
Prothena Biosciences Limited |
Verwendung von anti-mcam-antikörpern zur behandlung oder prophylaxe von riesenzellarteriitis, polymyalgia rheumatica oder takayasu-arteriitis
|
|
WO2017046774A2
(en)
|
2015-09-16 |
2017-03-23 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
|
|
KR20250057128A
(ko)
|
2015-12-30 |
2025-04-28 |
코디악 사이언시스 인코포레이티드 |
항체 및 이의 접합체
|
|
IL311107A
(en)
|
2016-02-17 |
2024-04-01 |
Seagen Inc |
BCMA antibodies and their use for the treatment of cancer and immune disorders
|
|
WO2017149513A1
(en)
|
2016-03-03 |
2017-09-08 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
|
CN116514976A
(zh)
|
2016-03-04 |
2023-08-01 |
Jn生物科学有限责任公司 |
针对tigit的抗体
|
|
WO2017153955A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
|
WO2017153953A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
|
EA201892412A1
(ru)
|
2016-05-02 |
2019-05-31 |
Протена Биосайенсис Лимитед |
Антитела, распознающие тау
|
|
CA3022673A1
(en)
|
2016-05-02 |
2017-11-09 |
Prothena Biosciences Limited |
Tau immunotherapy
|
|
CA3022515A1
(en)
|
2016-05-02 |
2017-11-09 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
WO2017208210A1
(en)
|
2016-06-03 |
2017-12-07 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
|
JP7016470B2
(ja)
|
2016-07-02 |
2022-02-07 |
プロセナ バイオサイエンシーズ リミテッド |
抗トランスサイレチン抗体
|
|
JP7017013B2
(ja)
|
2016-07-02 |
2022-02-08 |
プロセナ バイオサイエンシーズ リミテッド |
抗トランスサイレチン抗体
|
|
EP3478714A2
(de)
|
2016-07-02 |
2019-05-08 |
Prothena Biosciences Limited |
Anti-transthyretin-antikörper
|
|
AU2018250695A1
(en)
|
2017-04-14 |
2019-11-07 |
Kodiak Sciences Inc. |
Complement factor D antagonist antibodies and conjugates thereof
|
|
KR102784294B1
(ko)
|
2017-05-02 |
2025-03-19 |
프로테나 바이오사이언시즈 리미티드 |
타우 인식 항체
|
|
JP2021502955A
(ja)
|
2017-09-28 |
2021-02-04 |
プロセナ・バイオサイエンシズ・リミテッド |
シヌクレイン病の治療のための投与レジメン
|
|
PE20210042A1
(es)
|
2017-10-06 |
2021-01-08 |
Prothena Biosciences Ltd |
Metodos para detectar transtiretina
|
|
AU2018375356A1
(en)
|
2017-11-29 |
2020-05-14 |
Neotope Neuroscience Limited |
Lyophilized formulation of a monoclonal antibody against transthyretin
|
|
EP3508499A1
(de)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Antikörper zum targeting von, und andere modulatoren von, einem immunglobulingen im zusammenhang mit resistenz gegen antitumor-immunantworten und verwendungen davon
|
|
US12071476B2
(en)
|
2018-03-02 |
2024-08-27 |
Kodiak Sciences Inc. |
IL-6 antibodies and fusion constructs and conjugates thereof
|
|
TWI851577B
(zh)
|
2018-06-07 |
2024-08-11 |
美商思進公司 |
喜樹鹼結合物
|
|
BR112021003156A2
(pt)
|
2018-08-23 |
2021-05-11 |
Seagen, Inc. |
composição, anticorpo que se liga ao tigit humano, formulação farmacêutica, polinucleotídeo isolado, vetor, célula hospedeira, métodos para a produção de um anticorpo que se liga ao tigit humano e de anticorpos afucosilados que se ligam a tigit e para o tratamento de um câncer, e, kit.
|
|
EP3877410A4
(de)
|
2018-11-08 |
2022-08-10 |
Prothena Biosciences Limited |
Antikörper zur erkennung von tau
|
|
AU2019386976B2
(en)
|
2018-11-26 |
2024-05-30 |
Forty Seven, LLC |
Humanized antibodies against c-Kit
|
|
CA3120570A1
(en)
|
2018-11-28 |
2020-06-04 |
Forty Seven, Inc. |
Genetically modified hspcs resistant to ablation regime
|
|
CN109670423A
(zh)
*
|
2018-12-05 |
2019-04-23 |
依通(北京)科技有限公司 |
一种基于深度学习的图像识别系统、方法及介质
|
|
WO2020163225A1
(en)
|
2019-02-05 |
2020-08-13 |
Seattle Genetics, Inc. |
Anti-cd228 antibodies and antibody-drug conjugates
|
|
CN119371527A
(zh)
|
2019-03-03 |
2025-01-28 |
普罗塞纳生物科学有限公司 |
识别tau的抗体
|
|
KR20220051164A
(ko)
|
2019-07-05 |
2022-04-26 |
아이오엠엑스 테라퓨틱스 아게 |
Igsf11 (vsig3)의 항체 결합 igc2 및 이의 용도
|
|
KR20220075351A
(ko)
|
2019-10-04 |
2022-06-08 |
씨젠 인크. |
항-pd-l1 항체 및 항체-약물 접합체
|
|
AU2020364071A1
(en)
|
2019-10-10 |
2022-05-26 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
EP3822288A1
(de)
|
2019-11-18 |
2021-05-19 |
Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts |
Gegen das cd276-antigen gerichtete antikörper, und andere modulatoren gegen das cd276-antigen, und deren verwendung
|
|
IL294611B1
(en)
|
2020-01-08 |
2026-05-01 |
Regeneron Pharmaceuticals Inc |
Treatment of fibrodysplasia ossificans progressive
|
|
AU2021244215A1
(en)
|
2020-03-26 |
2022-10-13 |
Seagen Inc. |
Methods of treating multiple myeloma
|
|
US11820824B2
(en)
|
2020-06-02 |
2023-11-21 |
Arcus Biosciences, Inc. |
Antibodies to TIGIT
|
|
WO2022008027A1
(en)
|
2020-07-06 |
2022-01-13 |
Iomx Therapeutics Ag |
Antibodies binding igv of igsf11 (vsig3) and uses thereof
|
|
WO2022020680A1
(en)
|
2020-07-23 |
2022-01-27 |
Othair Prothena Limited |
Anti-abeta antibodies
|
|
US20230295330A1
(en)
|
2020-08-04 |
2023-09-21 |
Seagen Inc. |
Anti-cd228 antibodies and antibody-drug conjugates
|
|
CA3173151A1
(en)
|
2020-11-03 |
2022-05-12 |
Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts |
Target-cell restricted, costimulatory, bispecific and bivalent anti-cd28 antibodies
|
|
CN117120084A
(zh)
|
2021-01-28 |
2023-11-24 |
维肯芬特有限责任公司 |
用于调节b细胞介导的免疫应答的方法和手段
|
|
WO2022162203A1
(en)
|
2021-01-28 |
2022-08-04 |
Vaccinvent Gmbh |
Method and means for modulating b-cell mediated immune responses
|
|
AU2022212599A1
(en)
|
2021-01-28 |
2023-08-17 |
Universität Ulm |
Method and means for modulating b-cell mediated immune responses
|
|
WO2022217026A1
(en)
|
2021-04-09 |
2022-10-13 |
Seagen Inc. |
Methods of treating cancer with anti-tigit antibodies
|
|
TW202327650A
(zh)
|
2021-09-23 |
2023-07-16 |
美商思進公司 |
治療多發性骨髓瘤之方法
|
|
KR20250004779A
(ko)
|
2022-04-13 |
2025-01-08 |
길리애드 사이언시즈, 인코포레이티드 |
Trop-2 발현 암을 치료하기 위한 병용 요법
|
|
EP4508083A1
(de)
|
2022-04-13 |
2025-02-19 |
Gilead Sciences, Inc. |
Kombinationstherapie zur behandlung von tumorantigenexprimierenden krebsarten
|
|
WO2023215719A1
(en)
|
2022-05-02 |
2023-11-09 |
Arcus Biosciences, Inc. |
Anti-tigit antibodies and uses of the same
|
|
EP4594483A1
(de)
|
2022-09-28 |
2025-08-06 |
Deutsches Krebsforschungszentrum |
Modifizierte ace2-proteine mit verbesserter aktivität gegen sars-cov-2
|
|
AU2023372538A1
(en)
|
2022-11-03 |
2025-05-01 |
Seagen Inc. |
Anti-avb6 antibodies and antibody-drug conjugates and their use in the treatment of cancer
|
|
US20240226313A1
(en)
|
2022-11-17 |
2024-07-11 |
Sanofi |
Ceacam5 antibody-drug conjugates and methods of use thereof
|
|
EP4491230A1
(de)
|
2023-07-14 |
2025-01-15 |
iOmx Therapeutics AG |
Gegen leukozyten-immunglobulin-lirb1 (lilrb1) und lilrb2, gerichtete kreuzspezifische antigenbindende proteine (abp) und verwendungen davon
|
|
AU2023410277A1
(en)
|
2022-12-23 |
2025-06-12 |
Iomx Therapeutics Ag |
Cross-specific antigen binding proteins (abp) targeting leukocyte immunoglobulin-like receptor subfamily b1 (lilrb1) and lilrb2, combinations and uses thereof
|
|
TW202434629A
(zh)
|
2023-01-26 |
2024-09-01 |
愛爾蘭商歐薩爾普羅席納有限公司 |
以抗類澱粉β (ABETA)抗體治療神經病症之方法
|
|
WO2024191807A1
(en)
|
2023-03-10 |
2024-09-19 |
Seagen Inc. |
Methods of treating cancer with anti-tigit antibodies
|
|
WO2024249894A2
(en)
|
2023-06-02 |
2024-12-05 |
Arcus Biosciences, Inc. |
Biomarkers for predicting cancer treatment efficacy
|
|
AU2024341846A1
(en)
|
2023-09-15 |
2026-04-23 |
Prothena Biosciences Limited |
Cell penetrating agents and uses thereof
|
|
TW202530253A
(zh)
|
2023-09-15 |
2025-08-01 |
愛爾蘭商普羅希那生物科學有限公司 |
抗tdp-43抗體及其用途
|
|
AR133829A1
(es)
|
2023-09-15 |
2025-11-05 |
Othair Prothena Ltd |
Agentes penetrantes de células y usos de los mismos
|
|
TW202545567A
(zh)
|
2024-01-30 |
2025-12-01 |
美商思進公司 |
抗pd-l1抗體和抗體-藥物共軛體及彼等在治療癌症的用途
|
|
TW202602929A
(zh)
|
2024-03-21 |
2026-01-16 |
美商思進公司 |
Cd25抗體、抗體-藥物共軛體及彼等之用途
|
|
WO2026003224A2
(en)
|
2024-06-26 |
2026-01-02 |
Iomx Therapeutics Ag |
Bispecific antigen binding proteins (abp) targeting immune checkpoint molecules and both leukocyte immunoglobulin-like receptor subfamily b1 (lilrb1) and lilrb2; combinations and uses thereof
|
|
WO2026055669A2
(en)
|
2024-09-09 |
2026-03-12 |
Xencor, Inc. |
Anti-tl1a x anti-il23 antibodies
|